168 related articles for article (PubMed ID: 6159485)
1. Experience with serum alpha-fetoprotein and human chorionic gonadotropin in non-seminomatous testicular tumors.
Fowler JE; Taylor G; Blom J; Stutzman RE
J Urol; 1980 Sep; 124(3):365-8. PubMed ID: 6159485
[TBL] [Abstract][Full Text] [Related]
2. Serum alpha-fetoprotein and human chorionic gonadotropin in patients with seminoma.
Lange PH; Nochomovitz LE; Rosai J; Fraley EE; Kennedy BJ; Bosl G; Brisbane J; Catalona WJ; Cochran JS; Comisarow RH; Cummings KB; deKernion JB; Einhorn LH; Hakala TR; Jewett M; Moore MR; Scardino PT; Streitz JM
J Urol; 1980 Oct; 124(4):472-8. PubMed ID: 6158584
[TBL] [Abstract][Full Text] [Related]
3. The seminoma decoy: measurement of serum human chorionic gonadotropin in patients with seminoma.
Cochran JS
J Urol; 1976 Oct; 116(4):465-6. PubMed ID: 1053336
[TBL] [Abstract][Full Text] [Related]
4. The value of alpha-fetoprotein and beta-human chorionic gonadotrophin in the management of testicular tumours.
Narayana AS; Loening S; Culp DA
Br J Urol; 1978 Dec; 50(7):605-8. PubMed ID: 88986
[TBL] [Abstract][Full Text] [Related]
5. Relevance of biochemical tumor markers and lymphadenectomy in management of non-seminomatous testis tumors: current perspective.
Skinner DG; Scardino PT
J Urol; 1980 Mar; 123(3):378-82. PubMed ID: 6153725
[TBL] [Abstract][Full Text] [Related]
6. Serum markers in testicular tumors.
Narayana AS; Loening S; Weimar G; Culp DA
J Urol; 1979 Jan; 121(1):51-3. PubMed ID: 83396
[TBL] [Abstract][Full Text] [Related]
7. Serum alpha fetoprotein and human chorionic gonadotropin in the diagnosis and management of nonseminomatous germ-cell testicular cancer.
Lange PH; McIntire KR; Waldmann TA; Hakala TR; Fraley EE
N Engl J Med; 1976 Nov; 295(22):1237-40. PubMed ID: 62281
[No Abstract] [Full Text] [Related]
8. Tumor markers in patients with non-seminomatous germ cell tumors of the testis.
Willemse PH; Sleijfer DT; Schraffordt Koops H; De Bruijn HW; Oosterhuis JW; Brouwers TM; Ockhuizen T; Marrink J
Oncodev Biol Med; 1981; 2(1-2):117-28. PubMed ID: 6170952
[TBL] [Abstract][Full Text] [Related]
9. The management of patients with clinical stage I nonseminomatous testicular tumors and persistently elevated serologic markers.
Saxman SB; Nichols CR; Foster RS; Messemer JE; Donohue JP; Einhorn LH
J Urol; 1996 Feb; 155(2):587-9. PubMed ID: 8558665
[TBL] [Abstract][Full Text] [Related]
10. Tumour markers in testicular germ cell tumours. Five-year experience from the DATECA Study 1976-1980.
Nørgaard-Pedersen B; Schultz HP; Arends J; Brincker H; Krag Jacobsen G; Lindeløv B; Rørth M; Svennekjaer IL
Acta Radiol Oncol; 1984; 23(4):287-94. PubMed ID: 6208749
[TBL] [Abstract][Full Text] [Related]
11. Significance of elevated serum alphafetoprotein (AFP) in seminoma.
Javadpour N
Cancer; 1980 Apr; 45(8):2166-8. PubMed ID: 6154525
[TBL] [Abstract][Full Text] [Related]
12. Alpha-fetoprotein and human chorionic gonadotropin in the management of testicular tumors.
Lange PH; McIntire KR; Waldmann TA; Hakala TR; Fraley EE
J Urol; 1977 Oct; 118(4):593-6. PubMed ID: 72163
[TBL] [Abstract][Full Text] [Related]
13. Serum alpha-fetoprotein and human chorionic gonadotropin as markers for the effect of postoperative radiation therapy and/or chemotherapy in testicular cancer.
Schultz H; Sell A; Nørgaard-Pedersen B; Arends J
Cancer; 1978 Nov; 42(5):2182-6. PubMed ID: 82474
[TBL] [Abstract][Full Text] [Related]
14. Serum alpha-fetoprotein and human chorionic gonadotropin in the management of testicular tumors.
Lange PH
Natl Cancer Inst Monogr; 1978 Dec; (49):215-7. PubMed ID: 86163
[TBL] [Abstract][Full Text] [Related]
15. Should an elevated human chorionic gonadotropin titer alter therapy for seminoma?
Swartz DA; Johnson DE; Hussey DH
J Urol; 1984 Jan; 131(1):63-5. PubMed ID: 6690749
[TBL] [Abstract][Full Text] [Related]
16. [Significance of measurement of serum levels of tumor markers with germinal cell testicular tumor--value of beta-subunit human chorionic gonadotropin and alpha-fetoprotein (author's transl)].
Kamidono S; Arakawa S; Masuda M; Hamami G; Shimatani N; Itho N; Nakatsuka E; Fujii A; Ohono S; Ishigami J; Yoshimoto Y; Hattori M; Fujita T; Okada S
Nihon Hinyokika Gakkai Zasshi; 1980 Apr; 71(4):352-62. PubMed ID: 6157042
[No Abstract] [Full Text] [Related]
17. Clinical evaluation of basic fetoprotein in testicular cancer.
Harada K; Morishita S; Itani A; Nagata H; Hamami G; Ishii M; Kamidono S; Ishigami J
J Urol; 1987 Nov; 138(5):1178-80. PubMed ID: 2444719
[TBL] [Abstract][Full Text] [Related]
18. Serial monitoring of serum alpha-fetoprotein and chorionic gonadotropin in males with germ cell tumors.
Thompson DK; Haddow JE
Cancer; 1979 May; 43(5):1820-9. PubMed ID: 87255
[No Abstract] [Full Text] [Related]
19. Serum alpha-fetoprotein and human chorionic gonadotropin in the treatment of patients with testicular tumors.
Lange PH; Fraley EE
Urol Clin North Am; 1977 Oct; 4(3):393-406. PubMed ID: 76357
[No Abstract] [Full Text] [Related]
20. [Biological markers and germinal tumors of the testis. Value and limitations of the assay of chorionic gonadotrophin hormone and alpha-fetoprotein].
Bassoulet J; Pabot du Chatelard P; Ricordel I; Auberget JL; Guillemot MC; Merrer J; Timbal Y
J Urol (Paris); 1988; 94(8):393-6. PubMed ID: 2467947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
